BG104533A - Ген за психоматични разстройства - Google Patents
Ген за психоматични разстройства Download PDFInfo
- Publication number
- BG104533A BG104533A BG104533A BG10453300A BG104533A BG 104533 A BG104533 A BG 104533A BG 104533 A BG104533 A BG 104533A BG 10453300 A BG10453300 A BG 10453300A BG 104533 A BG104533 A BG 104533A
- Authority
- BG
- Bulgaria
- Prior art keywords
- disorder
- dna
- sequence
- yac
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9726804.9A GB9726804D0 (en) | 1997-12-18 | 1997-12-18 | Mood disorder gene |
PCT/EP1998/008543 WO1999032643A2 (en) | 1997-12-18 | 1998-12-17 | Mood disorder gene |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104533A true BG104533A (bg) | 2001-04-30 |
Family
ID=10823856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104533A BG104533A (bg) | 1997-12-18 | 2000-06-15 | Ген за психоматични разстройства |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1038015B1 (ja) |
JP (1) | JP2001526897A (ja) |
AT (1) | ATE329044T1 (ja) |
AU (1) | AU2514999A (ja) |
BG (1) | BG104533A (ja) |
CA (1) | CA2314437A1 (ja) |
DE (1) | DE69834831T2 (ja) |
ES (1) | ES2262256T3 (ja) |
GB (1) | GB9726804D0 (ja) |
HU (1) | HUP0100409A3 (ja) |
PL (1) | PL341814A1 (ja) |
TR (1) | TR200001965T2 (ja) |
WO (1) | WO1999032643A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001081906A1 (en) * | 2000-04-25 | 2001-11-01 | Spectrumedix Corporation | Denaturant-free electrophoresis of biological molecules under high temperature conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7089896A (en) * | 1995-09-23 | 1997-04-09 | Medical Research Council | Screening for disorders of serotonergic dysfunction |
FR2741088B1 (fr) * | 1995-11-10 | 1998-01-30 | Centre Nat Rech Scient | Methode de traitement de maladies neurodegeneratives mettant en oeuvre un anticorps ic2, un fragment ou derive de celui-ci et compositions pharmaceutiques correspondantes |
WO1997037043A1 (en) * | 1996-03-29 | 1997-10-09 | The Regents Of The University Of California | Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
-
1997
- 1997-12-18 GB GBGB9726804.9A patent/GB9726804D0/en not_active Ceased
-
1998
- 1998-12-17 CA CA002314437A patent/CA2314437A1/en not_active Abandoned
- 1998-12-17 AU AU25149/99A patent/AU2514999A/en not_active Abandoned
- 1998-12-17 ES ES98966865T patent/ES2262256T3/es not_active Expired - Lifetime
- 1998-12-17 TR TR2000/01965T patent/TR200001965T2/xx unknown
- 1998-12-17 PL PL98341814A patent/PL341814A1/xx not_active Application Discontinuation
- 1998-12-17 WO PCT/EP1998/008543 patent/WO1999032643A2/en not_active Application Discontinuation
- 1998-12-17 AT AT98966865T patent/ATE329044T1/de not_active IP Right Cessation
- 1998-12-17 DE DE69834831T patent/DE69834831T2/de not_active Expired - Fee Related
- 1998-12-17 JP JP2000525561A patent/JP2001526897A/ja active Pending
- 1998-12-17 HU HU0100409A patent/HUP0100409A3/hu unknown
- 1998-12-17 EP EP98966865A patent/EP1038015B1/en not_active Expired - Lifetime
-
2000
- 2000-06-15 BG BG104533A patent/BG104533A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
EP1038015A2 (en) | 2000-09-27 |
CA2314437A1 (en) | 1999-07-01 |
EP1038015B1 (en) | 2006-06-07 |
ES2262256T3 (es) | 2006-11-16 |
GB9726804D0 (en) | 1998-02-18 |
DE69834831D1 (de) | 2006-07-20 |
AU2514999A (en) | 1999-07-12 |
WO1999032643A2 (en) | 1999-07-01 |
HUP0100409A2 (hu) | 2001-06-28 |
HUP0100409A3 (en) | 2003-09-29 |
JP2001526897A (ja) | 2001-12-25 |
TR200001965T2 (tr) | 2000-12-21 |
PL341814A1 (en) | 2001-05-07 |
DE69834831T2 (de) | 2007-02-01 |
ATE329044T1 (de) | 2006-06-15 |
WO1999032643A3 (en) | 1999-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Flavigny et al. | Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy | |
JP4723550B2 (ja) | 生存運動ニューロン(smn)遺伝子;脊髄筋萎縮 | |
Hes et al. | Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene | |
Jeschke et al. | A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes | |
KR20000062427A (ko) | 질병의 대규모 유전자형 식별방법 및 척수소뇌성 운동실조 타입 6의 진단방법 | |
JP4312827B2 (ja) | ヒトのミューテーター遺伝子hMSH2及び遺伝性非ポリープ性大腸ガン | |
US6566064B1 (en) | Method for anticipating sensitivity to medicine for osteoporosis | |
AU693562B2 (en) | Method and probes for detecting markers bound to the locus of child spinal muscular atrophies | |
Kanters et al. | Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndrome | |
Growney et al. | Evolutionary divergence of the mouse and human Lgn1/SMA repeat structures | |
EP0711833A2 (en) | Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy | |
BG104533A (bg) | Ген за психоматични разстройства | |
ZA200509945B (en) | Methods for the diagnosis and prognosis of Alzheimer's disease | |
Moric-Janiszewska et al. | Mutational screening of SCN5A linked disorders in Polish patients and their family members | |
JP4776841B2 (ja) | 脈管形成分野におけるKrit1遺伝子の使用 | |
CN115927354B (zh) | 一种sh3tc2基因致病突变体及其在制备腓骨肌萎缩症4c型诊断试剂盒中的应用 | |
JP2000316577A (ja) | 成人発症ii型シトルリン血症の診断方法 | |
JP4048555B2 (ja) | 骨粗鬆症薬剤感受性予測方法 | |
Modibo et al. | GENOTYPIC SPECTRUM OF ALBINISM IN MALI | |
US7803538B2 (en) | Method for detecting Alzheimer's disease | |
Ging | Investigating the Role of Modifiers in Trinucleotide Repeat Diseases | |
JP3684921B2 (ja) | 骨粗鬆症薬剤感受性予測方法 | |
CZ20002282A3 (cs) | Gen asociovaný s poruchou nálady, jeho použití a způsob identifikace | |
Goossens | Cloning of candidate genes for bipolar disorder starting from expanded trinucleotide repeats | |
Esterhuizen | Duchenne muscular dystrophy: mutation profiling in view of the emerging gene-based therapies |